Which has stronger earnings and valuation, XAIR or HIND?

Vyome has lower revenue, but higher earnings than Beyond Air. Vyome is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Beyond Air $7.68M 0.48 -$33.25M -$88.00 N/A Vyome $320K 45.19 -$10.26M -$12.27 N/A

Is XAIR or HIND more profitable?

Vyome has a net margin of 0.00% compared to Beyond Air's net margin of -432.99%. Vyome's return on equity of -203.92% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -432.99% -350.00% -101.34% Vyome N/A -203.92% -134.16%

Do analysts rate XAIR or ZJYL?

Beyond Air presently has a consensus target price of $200.00, indicating a potential upside of 3,775.97%. Given Beyond Air's stronger consensus rating and higher possible upside, equities research analysts plainly believe Beyond Air is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beyond Air 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, XAIR or ZJYL?

Jin Medical International has higher revenue and earnings than Beyond Air. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Beyond Air $7.68M 0.48 -$33.25M -$88.00 N/A Jin Medical International $20.69M 0.65 $1.19M N/A N/A

Do analysts prefer OSRH or XAIR?

Beyond Air has a consensus target price of $200.00, suggesting a potential upside of 3,775.97%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts clearly believe Beyond Air is more favorable than OSR. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Beyond Air 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has higher valuation and earnings, OSRH or XAIR?

OSR has higher earnings, but lower revenue than Beyond Air. OSR is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OSR $2.63M 5.65 -$27.06M -$0.33 N/A Beyond Air $7.68M 0.48 -$33.25M -$88.00 N/A

Is OSRH or XAIR more profitable?

OSR has a net margin of -363.26% compared to Beyond Air's net margin of -432.99%. OSR's return on equity of -7.24% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets OSR -363.26% -7.24% -5.41% Beyond Air -432.99% -350.00% -101.34%

Is ICCM or XAIR more profitable?

Beyond Air has a net margin of -432.99% compared to IceCure Medical's net margin of -441.60%. IceCure Medical's return on equity of -211.73% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets IceCure Medical -441.60% -211.73% -119.13% Beyond Air -432.99% -350.00% -101.34%

Is XAIR or FEMY more profitable?

Beyond Air has a net margin of -432.99% compared to Femasys' net margin of -521.97%. Femasys' return on equity of -258.08% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -432.99% -350.00% -101.34% Femasys -521.97% -258.08% -73.72%

Beyond Air (XAIR) Competitors

$5.16 -0.31 (-5.67%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$5.22 +0.06 (+1.26%)

As of 07/24/2026 07:34 PM Eastern

Compare

XAIR vs. HIND, ZJYL, OSRH, ICCM, and FEMY

Should you buy Beyond Air stock or one of its competitors? MarketBeat compares Beyond Air with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Beyond Air include Vyome (HIND), Jin Medical International (ZJYL), OSR (OSRH), IceCure Medical (ICCM), and Femasys (FEMY). These companies are all part of the "medical equipment" industry.

How does Beyond Air compare to Vyome?

Beyond Air (NASDAQ:XAIR) and Vyome (NASDAQ:HIND) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

In the previous week, Beyond Air had 1 more articles in the media than Vyome. MarketBeat recorded 2 mentions for Beyond Air and 1 mentions for Vyome. Vyome's average media sentiment score of 1.87 beat Beyond Air's score of 1.44 indicating that Vyome is being referred to more favorably in the news media.

Company	Overall Sentiment
Beyond Air	Positive
Vyome	Very Positive

Vyome has lower revenue, but higher earnings than Beyond Air. Vyome is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.48	-$33.25M	-$88.00	N/A
Vyome	$320K	45.19	-$10.26M	-$12.27	N/A

Beyond Air has a beta of 0.22, suggesting that its share price is 78% less volatile than the broader market. Comparatively, Vyome has a beta of 1.49, suggesting that its share price is 49% more volatile than the broader market.

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 22.1% of Vyome shares are held by institutional investors. 10.0% of Beyond Air shares are held by insiders. Comparatively, 33.0% of Vyome shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Vyome has a net margin of 0.00% compared to Beyond Air's net margin of -432.99%. Vyome's return on equity of -203.92% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-432.99%	-350.00%	-101.34%
Vyome	N/A	-203.92%	-134.16%

Beyond Air presently has a consensus price target of $200.00, suggesting a potential upside of 3,775.97%. Vyome has a consensus price target of $15.00, suggesting a potential upside of 628.16%. Given Beyond Air's higher probable upside, research analysts clearly believe Beyond Air is more favorable than Vyome.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Vyome beats Beyond Air on 10 of the 16 factors compared between the two stocks.

How does Beyond Air compare to Jin Medical International?

Beyond Air (NASDAQ:XAIR) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends, profitability and media sentiment.

In the previous week, Jin Medical International had 2 more articles in the media than Beyond Air. MarketBeat recorded 4 mentions for Jin Medical International and 2 mentions for Beyond Air. Beyond Air's average media sentiment score of 1.44 beat Jin Medical International's score of 0.50 indicating that Beyond Air is being referred to more favorably in the media.

Company	Overall Sentiment
Beyond Air	Positive
Jin Medical International	Positive

Beyond Air has a beta of 0.22, indicating that its share price is 78% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.34, indicating that its share price is 634% more volatile than the broader market.

31.5% of Beyond Air shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Jin Medical International has higher revenue and earnings than Beyond Air.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.48	-$33.25M	-$88.00	N/A
Jin Medical International	$20.69M	0.65	$1.19M	N/A	N/A

Beyond Air presently has a consensus target price of $200.00, indicating a potential upside of 3,775.97%. Given Beyond Air's stronger consensus rating and higher possible upside, equities research analysts plainly believe Beyond Air is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Jin Medical International has a net margin of 0.00% compared to Beyond Air's net margin of -432.99%. Jin Medical International's return on equity of 0.00% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-432.99%	-350.00%	-101.34%
Jin Medical International	N/A	N/A	N/A

Summary

Jin Medical International beats Beyond Air on 8 of the 14 factors compared between the two stocks.

How does Beyond Air compare to OSR?

OSR (NASDAQ:OSRH) and Beyond Air (NASDAQ:XAIR) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, media sentiment, risk, dividends and earnings.

OSR has a net margin of -363.26% compared to Beyond Air's net margin of -432.99%. OSR's return on equity of -7.24% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OSR	-363.26%	-7.24%	-5.41%
Beyond Air	-432.99%	-350.00%	-101.34%

55.3% of OSR shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 36.9% of OSR shares are held by insiders. Comparatively, 10.0% of Beyond Air shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Beyond Air has a consensus target price of $200.00, suggesting a potential upside of 3,775.97%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts clearly believe Beyond Air is more favorable than OSR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, OSR and OSR both had 2 articles in the media. Beyond Air's average media sentiment score of 1.44 beat OSR's score of 1.31 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Overall Sentiment
OSR	Positive
Beyond Air	Positive

OSR has higher earnings, but lower revenue than Beyond Air. OSR is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OSR	$2.63M	5.65	-$27.06M	-$0.33	N/A
Beyond Air	$7.68M	0.48	-$33.25M	-$88.00	N/A

OSR has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market.

Summary

OSR beats Beyond Air on 9 of the 15 factors compared between the two stocks.

How does Beyond Air compare to IceCure Medical?

IceCure Medical (NASDAQ:ICCM) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends.

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 2.4% of IceCure Medical shares are held by company insiders. Comparatively, 10.0% of Beyond Air shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, IceCure Medical had 1 more articles in the media than Beyond Air. MarketBeat recorded 3 mentions for IceCure Medical and 2 mentions for Beyond Air. Beyond Air's average media sentiment score of 1.44 beat IceCure Medical's score of 0.96 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Overall Sentiment
IceCure Medical	Positive
Beyond Air	Positive

IceCure Medical has higher earnings, but lower revenue than Beyond Air. IceCure Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.57M	2.96	-$15.06M	-$7.21	N/A
Beyond Air	$7.68M	0.48	-$33.25M	-$88.00	N/A

Beyond Air has a net margin of -432.99% compared to IceCure Medical's net margin of -441.60%. IceCure Medical's return on equity of -211.73% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-441.60%	-211.73%	-119.13%
Beyond Air	-432.99%	-350.00%	-101.34%

IceCure Medical currently has a consensus price target of $62.70, suggesting a potential upside of 1,935.71%. Beyond Air has a consensus price target of $200.00, suggesting a potential upside of 3,775.97%. Given Beyond Air's higher probable upside, analysts clearly believe Beyond Air is more favorable than IceCure Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

IceCure Medical has a beta of 0.43, indicating that its stock price is 57% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market.

Summary

IceCure Medical and Beyond Air tied by winning 8 of the 16 factors compared between the two stocks.

How does Beyond Air compare to Femasys?

Beyond Air (NASDAQ:XAIR) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 65.3% of Femasys shares are held by institutional investors. 10.0% of Beyond Air shares are held by company insiders. Comparatively, 7.8% of Femasys shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Beyond Air has a net margin of -432.99% compared to Femasys' net margin of -521.97%. Femasys' return on equity of -258.08% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-432.99%	-350.00%	-101.34%
Femasys	-521.97%	-258.08%	-73.72%

Femasys has lower revenue, but higher earnings than Beyond Air. Femasys is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.48	-$33.25M	-$88.00	N/A
Femasys	$2.38M	4.71	-$18.63M	-$5.40	N/A

Beyond Air has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market. Comparatively, Femasys has a beta of -2.13, meaning that its share price is 313% less volatile than the broader market.

In the previous week, Beyond Air and Beyond Air both had 2 articles in the media. Beyond Air's average media sentiment score of 1.44 beat Femasys' score of 0.94 indicating that Beyond Air is being referred to more favorably in the media.

Company	Overall Sentiment
Beyond Air	Positive
Femasys	Positive

Beyond Air currently has a consensus target price of $200.00, suggesting a potential upside of 3,775.97%. Femasys has a consensus target price of $106.67, suggesting a potential upside of 2,775.11%. Given Beyond Air's higher possible upside, analysts plainly believe Beyond Air is more favorable than Femasys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Femasys beats Beyond Air on 8 of the 15 factors compared between the two stocks.

Get Beyond Air News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XAIR vs. The Competition

Export

Metric	Beyond Air	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.94M	$3.67B	$6.87B	$12.26B
Dividend Yield	N/A	2.19%	2.67%	9.79%
P/E Ratio	-0.06	21.29	27.11	23.64
Price / Sales	0.48	170.12	517.09	89.57
Price / Cash	N/A	157.90	50.54	59.64
Price / Book	0.55	7.88	10.28	6.07
Net Income	-$33.25M	$23.86M	$3.60B	$331.99M
7 Day Performance	-7.53%	-3.82%	-1.27%	-0.63%
1 Month Performance	-45.95%	-2.61%	-0.37%	-2.00%
1 Year Performance	-91.94%	32.79%	18.30%	13.62%

Beyond Air Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XAIR Beyond Air	3.3553 of 5 stars	$5.16 -5.7%	$200.00 +3,776.0%	-92.2%	$3.94M	$7.68M	N/A	70	Positive News Analyst Forecast Short Interest Decrease
HIND Vyome	3.0994 of 5 stars	$2.22 +1.8%	$15.00 +575.7%	N/A	$15.73M	$320K	N/A	50	Positive News
ZJYL Jin Medical International	0.6105 of 5 stars	$2.00 +2.0%	N/A	-85.1%	$15.66M	$20.69M	N/A	245	Short Interest Increase
OSRH OSR	0.9748 of 5 stars	$0.38 +3.6%	N/A	-56.0%	$13.16M	$2.91M	N/A	N/A	Gap Up
ICCM IceCure Medical	3.6651 of 5 stars	$3.60 0.0%	$62.70 +1,642.2%	-89.6%	$12.28M	$3.38M	N/A	60	Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XAIR) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beyond Air (XAIR) Competitors